1.
Esmail A, Rayyan Y, Rayyan H, Abdelrahim M. Evaluating Standardization of Neoadjuvant Immunotherapy in Transplant-Eligible Hepatocellular Carcinoma Populations. Jordan Med. J. [Internet]. 2025 Feb. 10 [cited 2025 Dec. 25];59(1). Available from: https://jjournals.ju.edu.jo/index.php/JMJ/article/view/3957